CLINICAL_TRIALS
research
· 2026-03-27
Clinical Trial Update: Study of APG-2575 in Patients With Relapsed/Refractory CLL/SLL [Phase 2]
Summary
Phase 2 clinical trial update for APG-2575 in relapsed/refractory chronic lymphocytic leukemia and small lymphocytic lymphoma; the study is currently recruiting…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Ascentage Pharma Group Inc. | Conditions: Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma | Phase 2 | Status: RECRUITING